Comparison of escitalopram and citalopram efficacy: A meta-analysis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International journal of psychiatry in clinical practice

• Publication date

  2003-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1080/13651500310003408PMID 24930412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice.

  2025cited by this paper
• The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer

  2005cited by this paper
• Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care.

  2003cited by this paper
• Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

  2003cited by this paper
• Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

  2003cited by this paper
• Placebo Response and Antidepressant Clinical Trial Outcome

  2003cited by this paper
• The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.

  2003cited by this paper
• Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo‐controlled study in depression in primary care

  2003cited by this paper
• Escitalopram

  2003cited by this paper
• R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model.

  2003cited by this paper
• Comparing the methods used to compare antidepressants.

  2002cited by this paper
• Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.

  2002influential reference
• Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials

  2002influential reference
• Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

  2002cited by this paper
• Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.

  2001cited by this paper
• Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

  2000cited by this paper
• Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.

  2000cited by this paper
• Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors

  1999cited by this paper
• Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

  1997cited by this paper
• Meta-analytic Tools for Medical Decision Making: A Practical Guide

  1995cited by this paper
• Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].

  1994cited by this paper
• The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

  1994cited by this paper
• A meta-analysis of the efficacy of selective serotonin reuptake inhibitors compared to tricyclic antidepressants in depression

  1994cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Separate site(s) of action of optical isomers of 1-methyl-5-phenyl-5-propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex.

  1985cited by this paper
• Effects of picenadol and its agonist and antagonist isomers on schedule-controlled behavior.

  1983cited by this paper
• A New Depression Scale Designed to be Sensitive to Change

  1979cited by this paper
• Meta-analysis of psychotherapy outcome studies.

  1977cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• COMPARATIVE EFFICACY OF ESCITALOPRAM VERSUS OTHER ANTIDEPRESSANTS IN ADULTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

  2025cites this paper
• Chirality of New Drug Approvals (2013–2022): Trends and Perspectives

  2024cites this paper
• Chirality of antidepressive drugs: an overview of stereoselectivity

  2022cites this paper
• Sensory Adaptation Training or Escitalopram for IBS With Constipation and Rectal Hypersensitivity: A Randomized Controlled Trial

  2021cites this paper
• Serotonin Reuptake Inhibitors: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline

  2021cites this paper
• A prospective study to compare the efficacy of vilazodone and escitalopram tablets in the treatment of patients with newly diagnosed major depressive disorder

  2020cites this paper
• Effect of Baseline Severity on Antidepressant Efficacy of Escitalopram and Milnacipranat Tertiary Heath Care Center

  2018cites this paper
• Chirality of Modern Antidepressants: An Overview

  2017cites this paper
• Stereo‐Psychopharmacology: The Case of Citalopram and Escitalopram

  2016cites this paper
• In vivo investigation of escitalopram's allosteric site on the serotonin transporter.

  2016cites this paper
• A Population Pharmacokinetic–Pharmacodynamic Meta‐Analysis of Vortioxetine in Patients with Major Depressive Disorder

  2016cites this paper
• Escitalopram zur Prävention Interferon-alpha-induzierter Depressionen bei Patienten mit einer chronischen Hepatitis-C-Infektion

  2015cites this paper
• Pharmacokinetics and Bioavailability Comparison of two oral Tablet Formulations of Escitalopram 20 mg: A Single-Dose, Open-Label, Two-Period Crossover Study in Healthy Indian Adult Subjects

  2014cites this paper
• Wpływ escitalopramu, nortryptyliny i wenlafaksyny na objawy bólowe w depresji

  2014cites this paper
• Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies

  2013cites this paper
• Correspondence (reply): In reply.

  2013cites this paper
• Escitalopram

  2012cites this paper
• A randomized, prospective pilot study of patient expectancy and antidepressant outcome

  2012cites this paper
• Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study

  2011cites this paper
• Efficacy of escitalopram compared to citalopram: a meta-analysis.

  2011cites this paper
• Comparative efficacy of escitalopram in the treatment of major depressive disorder

  2011cites this paper
• Serum Concentrations of Citalopram – Dose-Dependent Variation in R- and S-Enantiomer Ratios

  2010cites this paper
• Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters.

  2009cites this paper
• Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

  2009influential citation
• Escitalopram increases cortical nitric oxide synthase (NOS) in rat brain during ethanol withdrawal.

  2008cites this paper
• Escitalopram for the treatment of major depression and anxiety disorders

  2008cites this paper
• Einsatz einer modifizierten MADRS bei depressiven Patienten in einer prospektiven Kohortenstudie

  2007cites this paper
• Serotonergic anti-depressants and ethanol withdrawal syndrome: a review.

  2007cites this paper
• Escitalopram, un développement clinique complet

  2007cites this paper
• A Qualitative Review of Recent Economic Evaluations of Escitalopram

  2007cites this paper
• Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

  2007cites this paper
• Which antidepressants have demonstrated superior efficacy? A review of the evidence

  2007cites this paper
• Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

  2007influential citation
• Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder

  2007cites this paper
• Antidepressants, serotonin and cognition : applied and fundamental studies in human volunteers

  2007cites this paper
• [Prospective study using a modified Montgomery-Asberg Depression Scale].

  2007cites this paper
• Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria

  2007cites this paper
• Safety and Efficacy of Oral Escitalopram as Continuation Treatment of Intravenous Citalopram in Patients with Major Depressive Disorder

  2007cites this paper
• Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

  2007cites this paper
• Efficacy, effectiveness and efficiency of escitalopram in the treatment of major depressive and anxiety disorders

  2007cites this paper
• Managing depressive and anxiety disorders with escitalopram

  2006cites this paper
• Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions.

  2006cites this paper
• Evidence-based treatment of anxiety disorders

  2006cites this paper
• Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

  2006cites this paper
• Escitalopram versus venlafaxine XR in the treatment of depression

  2006cites this paper
• Why do we need new and better antidepressants?

  2006cites this paper
• Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis

  2006influential citation
• A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients

  2006cites this paper
• A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder

  2006cites this paper
• New Possibilities of Treatment for Panic Attacks in Elderly Patients: Escitalopram Versus Citalopram

  2006cites this paper
• Effects of escitalopram on ethanol withdrawal syndrome in rats.

  2006cites this paper
• Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities

  2006cites this paper
• The importance of long-term tolerability in achieving recovery

  2006cites this paper
• The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram.

  2006cites this paper
• Spotlight on Escitalopram in the Management of Major Depressive Disorder

  2006cites this paper
• The Influence of Baseline Severity on Efficacy of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: An Extended Analysis

  2006cites this paper
• Comparison of escitalopram and citalopram in outpatients with severe major depressive disorder: a prospective, naturalistic, 8-week study

  2006cites this paper
• Estsitalopraami efektiivsus depressiooni ravis võrrelduna konventsionaalsete selektiivsete serotoniini tagasihaarde inhibiitorite ja venlafaksiin XRiga: metaanalüüs

  2006cites this paper
• Efficacy of escitalopram in patients with severe depression: a pooled analysis

  2005cites this paper
• Zielvereinbarung 2005 zwischen GKV und KV-Hamburg - Ausgabensenkung um 1 % u.a. bei Antidepressiva blockiert Teilhabe der Kranken am Fortschritt

  2005cites this paper
• A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder*

  2005cites this paper
• [A new quality of the therapy of anxiety and depression--escitalopram].

  2005cites this paper
• Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

  2005influential citation
• Traitement des épisodes dépressifs sévères : escitalopram est plus efficace que citalopram

  2004cites this paper
• [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

  2004cites this paper
• Escitalopram versus citalopram: the surprising role of the R-enantiomer

  2004cites this paper
• Evidence based review of escitalopram in treating major depressive disorder in primary care

  2004cites this paper
• Current awareness in human psychopharmacology

  2004cites this paper
• Spotlight on the Pharmacoeconomics of Escitalopram in Depression

  2004cites this paper
• A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

  2004cites this paper
• Gateways to clinical trials.

  2004cites this paper
• Unique mechanism of action for escitalopram: does it hold the promise?

  2004cites this paper
• Escitalopram: a pharmacoeconomic review of its use in depression.

  2003cites this paper
• Psychopharmaka-Verordnungen - Ergebnisse und Kommentare zum Arzneiverordnungsreport 2004

  2003cites this paper